Adel Ersek

Norwich Research Park
Norwich, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

RUNX2 inhibitor CADD522 improves bone microarchitecture and lipid metabolism in post-menopausal bone loss.

RUNX2 inhibitor CADD522 improves bone microarchitecture and lipid metabolism in post-menopausal bone loss.

Journal: npj drug discovery
Published: January 08, 2025

The microRNA-455 null mouse shows dysregulated bone turnover.

The microRNA-455 null mouse shows dysregulated bone turnover.

Journal: JBMR plus
Published: October 09, 2024

Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease.

Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease.

Journal: Nature communications
Published: July 17, 2021

Strain dependent differences in glucocorticoid-induced bone loss between C57BL/6J and CD-1 mice.

Strain dependent differences in glucocorticoid-induced bone loss between C57BL/6J and CD-1 mice.

Journal: Scientific reports
Published: May 26, 2016

Selective inhibition of TNFR1 reduces osteoclast numbers and is differentiated from anti-TNF in a LPS-driven model of inflammatory bone loss.

Selective inhibition of TNFR1 reduces osteoclast numbers and is differentiated from anti-TNF in a LPS-driven model of inflammatory bone loss.

Journal: Biochemical and biophysical research communications
Published: July 13, 2015

Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune response.

Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune response.

Journal: EMBO molecular medicine
Published: March 16, 2015

Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.

Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.

Journal: The Journal of clinical investigation
Published: September 16, 2014

Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases.

Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases.

Journal: Frontiers in endocrinology
Published: May 09, 2012

Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation.

Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation.

Journal: PloS one
Published: April 16, 2012
Showing 1-9 of 9

Last Updated: 09/26/2026